MCID: END047
MIFTS: 45

Endophthalmitis malady

Categories: Eye diseases, Rare diseases

Aliases & Classifications for Endophthalmitis

Aliases & Descriptions for Endophthalmitis:

Name: Endophthalmitis 12 56 52 42 14 69

Classifications:

MalaCards categories:
Global: Rare diseases
Anatomical: Eye diseases
Orphanet: 56  
Rare eye diseases


External Ids:

Disease Ontology 12 DOID:4692
MeSH 42 D009877
NCIt 47 C34586
Orphanet 56 ORPHA199323
ICD10 via Orphanet 34 H44.0 H44.1
MESH via Orphanet 43 D009877
UMLS via Orphanet 70 C0014236
ICD10 33 H45.1
UMLS 69 C0014236

Summaries for Endophthalmitis

Disease Ontology : 12 A globe disease that is characterized by inflammation of the inside of the eye.

MalaCards based summary : Endophthalmitis is related to acute endophthalmitis and chronic endophthalmitis, and has symptoms including redness or discharge of eye An important gene associated with Endophthalmitis is DEFB1 (Defensin Beta 1), and among its related pathways/superpathways are Development VEGF signaling via VEGFR2 - generic cascades and Fluid shear stress and atherosclerosis. The drugs Cefazolin and Lidocaine have been mentioned in the context of this disorder. Affiliated tissues include eye, liver and endothelial.

Wikipedia : 71 Endophthalmitis is an inflammation of the interior of the eye. It is a possible complication of all... more...

Related Diseases for Endophthalmitis

Diseases in the Endophthalmitis family:

Chronic Endophthalmitis Acute Endophthalmitis

Diseases related to Endophthalmitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 166)
id Related Disease Score Top Affiliating Genes
1 acute endophthalmitis 12.1
2 chronic endophthalmitis 12.1
3 purulent endophthalmitis 12.1
4 phacoanaphylactic uveitis 11.1
5 cataract 10.5
6 sympathetic ophthalmia 10.4
7 cardiac tuberculosis 10.3 MRAP VEGFA
8 athabaskan brainstem dysgenesis syndrome 10.3 MRAP VEGFA
9 neonatal antiphospholipid syndrome 10.3 DEFB1 VEGFA
10 urethral intrinsic sphincter deficiency 10.2 MRAP SELE
11 tonsil cancer 10.2 ICAM1 SELE
12 hypopyon ulcer 10.2 ICAM1 SELE
13 macrodactyly of the foot 10.2 ICAM1 SELE
14 congenital ichthyosiform erythroderma 10.2 OPTN VEGFA
15 tick paralysis 10.2 ICAM1 SELE
16 visual epilepsy 10.2 CRYAA VEGFA
17 extrahepatic bile duct papillary adenoma 10.2 MRAP PRF1
18 pyriform sinus cancer 10.2 ICAM1 VEGFA
19 periosteal chondrosarcoma 10.2 ICAM1 SELE
20 sparganosis 10.2 ICAM1 SELE
21 madras motor neuron disease 10.2 HMGB1 PRF1
22 right ventricle hypoplasia 10.2 ICAM1 SELE
23 lymph node disease 10.2 ICAM1 SELE
24 multilocular clear cell renal cell carcinoma 10.1 ICAM1 MRAP VEGFA
25 pneumonia 10.1
26 skin granular cell tumor 10.1 MRAP OPTN
27 dermatomycosis 10.1 ICAM1 SELE
28 cryptosporidiosis 10.1 CRYAA VEGFA
29 hereditary night blindness 10.1 DEFB1 SELE
30 mechanical strabismus 10.1 CRYAA OPTN
31 pelvic varices 10.1 MRAP OPTN VEGFA
32 phlegmonous dacryocystitis 10.1 ICAM1 SELE VEGFA
33 olecranon bursitis 10.1 CRYAA OPTN
34 craniopharyngioma 10.1 ICAM1 SELE
35 pyrimidine metabolic disorder 10.1 ICAM1 SELE VEGFA
36 retinitis 10.1
37 erb-duchenne and dejerine-klumpke palsies 10.1 ICAM1 SELE
38 dracunculiasis 10.1 ICAM1 SELE
39 congenital toxoplasmosis 10.1 CRYGS VEGFA
40 autoimmune-related retinopathy and optic neuropathy 10.0 ICAM1 SELE VEGFA
41 keratitis 10.0
42 brucella canis brucellosis 10.0 CRYAA VEGFA
43 endotheliitis 10.0
44 endometrial stromal nodule 10.0 CRYAA CRYGS
45 uveitis 10.0
46 female breast lower-outer quadrant cancer 10.0 CRYAA CRYGS
47 meningitis 10.0
48 hypopyon 10.0
49 cellulitis 10.0
50 powassan encephalitis 9.9 ICAM1 SELE

Graphical network of the top 20 diseases related to Endophthalmitis:



Diseases related to Endophthalmitis

Symptoms & Phenotypes for Endophthalmitis

UMLS symptoms related to Endophthalmitis:


redness or discharge of eye

Drugs & Therapeutics for Endophthalmitis

Drugs for Endophthalmitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 192)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cefazolin Approved Phase 4 25953-19-9 656510 33255
2
Lidocaine Approved, Vet_approved Phase 4 137-58-6 3676
3
Ephedrine Approved Phase 4,Phase 2 299-42-3 9294
4
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 50-28-2 5757 53477783
5
Ethinyl Estradiol Approved Phase 4,Phase 3,Phase 2 57-63-6 5991
6
Moxifloxacin Approved, Investigational Phase 4,Phase 3,Phase 2 354812-41-2, 151096-09-2 152946
7
Norgestimate Approved Phase 4,Phase 3,Phase 2 35189-28-7 6540478
8
Pseudoephedrine Approved Phase 4,Phase 2 90-82-4 7028
9
Methylprednisolone Approved, Vet_approved Phase 4,Phase 1,Phase 2 83-43-2 6741
10
Prednisolone Approved, Vet_approved Phase 4,Phase 1,Phase 2 50-24-8 5755
11
Triamcinolone Approved, Vet_approved Phase 4,Phase 1,Phase 2 124-94-7 31307
12
Povidone-iodine Approved Phase 4 25655-41-8
13
Clindamycin Approved, Vet_approved Phase 4 18323-44-9 29029
14
Glycerol Approved, Experimental Phase 4 56-81-5 753
15
Loteprednol Approved Phase 4 82034-46-6, 129260-79-3 444025 9865442
16
Levofloxacin Approved, Investigational Phase 4 100986-85-4 149096
17
Ofloxacin Approved Phase 4 82419-36-1 4583
18
Ranibizumab Approved Phase 4,Phase 3,Phase 2,Phase 1 347396-82-1 459903
19
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
20
Hyaluronic acid Approved, Vet_approved Phase 4 9004-61-9 53477741 24759
21 Anesthetics Phase 4
22 Anesthetics, Local Phase 4
23 Anti-Arrhythmia Agents Phase 4
24 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1
25 Antibiotics, Antitubercular Phase 4,Phase 3,Phase 2,Phase 1
26 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1
27 Antitubercular Agents Phase 4,Phase 3
28 Central Nervous System Depressants Phase 4
29 Cephalosporins Phase 4
30 Diuretics, Potassium Sparing Phase 4
31 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2
32 Pharmaceutical Solutions Phase 4,Phase 3,Phase 2
33 Sodium Channel Blockers Phase 4
34 Autonomic Agents Phase 4,Phase 2
35 Contraceptive Agents Phase 4,Phase 3,Phase 2
36 Contraceptives, Oral Phase 4,Phase 3,Phase 2
37 Contraceptives, Oral, Combined Phase 4,Phase 3,Phase 2
38 Estradiol 17 beta-cypionate Phase 4,Phase 3,Phase 2
39 Estradiol 3-benzoate Phase 4,Phase 3,Phase 2
40 Estradiol valerate Phase 4,Phase 3,Phase 2 979-32-8
41 Fluoroquinolones Phase 4,Phase 3,Phase 2
42 Nasal Decongestants Phase 4,Phase 2
43 Norgestimate, ethinyl estradiol drug combination Phase 4,Phase 3,Phase 2
44 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 3,Phase 2,Phase 1
45 Ophthalmic Solutions Phase 4,Phase 3,Phase 2,Phase 1
46 Polyestradiol phosphate Phase 4,Phase 3,Phase 2
47 Respiratory System Agents Phase 4,Phase 3,Phase 2
48 Tetrahydrozoline Phase 4,Phase 1,Phase 2
49 Topoisomerase Inhibitors Phase 4,Phase 3,Phase 2,Phase 1
50 Vasoconstrictor Agents Phase 4,Phase 2

Interventional clinical trials:

(show top 50) (show all 100)
id Name Status NCT ID Phase
1 Cefazolin-Lidocaine Combination Solution to Reduce Antibiotic Pain Unknown status NCT02324166 Phase 4
2 Dosage Study for Vigamox Eye Drops Prior to Intravitreal Injections Unknown status NCT00690313 Phase 4
3 IntraVitreal Triamcinolone Acetonide: Preventing Raised Eye-pressure by Tracking Elevations After Topical Steroids Unknown status NCT00744666 Phase 4
4 Prophylaxis of Acute Post-Traumatic Bacterial Endophthalmitis Completed NCT00398658 Phase 4
5 Povidone-iodine Antisepsis for Strabismus Surgery Completed NCT00461656 Phase 4
6 The Utility of in Vivo Confocal Microscopy to Assess Cellular Response and Efficacy of Long-term Topical Steroid Treatment in Patients With Dry Eye Disease Completed NCT02120079 Phase 4
7 Comparative Efficacy of Different Regimens of PVPI 5% Eye Drops Instillation in Reducing Conjunctival Bacterial Flora Completed NCT01739920 Phase 4
8 Effectiveness of Topical 0.5% Levofloxacin to Reduce the Conjunctival Bacterial Flora Before Intraocular Surgery Completed NCT00491049 Phase 4
9 Aurolab Hydrophobic Foldable Intraocular Lens Study Completed NCT00449267 Phase 4
10 Intravitreal Aflibercept Injection for the Treatment of Submacular Vascularized Pigment Epithelial Detachment Completed NCT01722656 Phase 4
11 Hyaluronic Acid Gels for Upper Lid Retraction in Active Stage Thyroid Eye Disease Recruiting NCT01738243 Phase 4
12 Influence of Diabetes Control on Treatment of Diabetic Macular Edema With Ranibizumab Recruiting NCT02665689 Phase 4
13 Frozen Versus Fresh Corneal Carriers for the Boston KPro Type I Donor Carriers Enrolling by invitation NCT01950598 Phase 4
14 Fluconazole Versus Micafungin for Candida Bloodstream Infection in Non-Neutropenic Patients Withdrawn NCT00304772 Phase 4
15 Interest of Intravitreal Corticotherapy as the First-line Treatment for Post-operative Endophthalmitis Unknown status NCT01768078 Phase 3
16 The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid Arthritis Unknown status NCT00012506 Phase 3
17 Endophthalmitis Vitrectomy Study (EVS) Completed NCT00000130 Phase 3
18 Clinical Trial of Eye Prophylaxis in the Newborn Completed NCT00000120 Phase 3
19 Retaane® in Age-Related Macular Degeneration Completed NCT00569569 Phase 2, Phase 3
20 Systemic Avastin Therapy in Age-Related Macular Degeneration Completed NCT00531024 Phase 2, Phase 3
21 Effect of Intravitreal Ranibizumab Injection With Retinal Vein Occlusion (RVO) Completed NCT00942864 Phase 3
22 Efficacy and Safety Study of Cyclosporine 0.010% to Treat Atopic Keratoconjunctivitis Completed NCT00884585 Phase 3
23 Evaluation of Efficacy and Safety of Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis. Recruiting NCT02770729 Phase 3
24 A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behcet's Disease Active, not recruiting NCT02307513 Phase 3
25 Evaluate Azithromycin Plus Chloroquine And Sulfadoxine Plus Pyrimethamine Combinations For Intermittent Preventive Treatment Of Falciparum Malaria Infection In Pregnant Women In Africa Terminated NCT01103063 Phase 3
26 The Effect of Intravitral Injection of Triamcinolone Combined With Cataract Surgery (Phacoemulsification) on Diabetic Macular Edema and Diabetic Retinopathy Unknown status NCT00849537 Phase 1, Phase 2
27 Safety Study of Conventional Versus Micropulse Transscleral Cyclophotocoagulation in Treating End-Stage Glaucoma Unknown status NCT00349414 Phase 1, Phase 2
28 TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid Arthritis Completed NCT00001862 Phase 2
29 Modified Intraocular Lens to Reduce Eye Inflammation After Cataract Surgery in Uveitis Patients Completed NCT00001311 Phase 2
30 Combination Ranibizumab and Bromfenac for Neovascular Age-related Macular Degeneration Completed NCT00805233 Phase 2
31 Ranibizumab and Reduced Fluence PDT for AMD Completed NCT00527475 Phase 2
32 Leflunomide to Treat Uveitis Completed NCT00001863 Phase 2
33 HAT in Eye Complications of Behcet's Disease Completed NCT00001865 Phase 2
34 Daclizumab to Treat Non-Infectious Sight-Threatening Uveitis Completed NCT00070759 Phase 2
35 Daclizumab Injections to Treat Non-Infectious Sight-Threatening Uveitis Completed NCT00043667 Phase 2
36 RTA 408 Ophthalmic Suspension for the Treatment of Ocular Inflammation and Pain Following Ocular Surgery Completed NCT02065375 Phase 2
37 Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis Completed NCT01789320 Phase 1, Phase 2
38 Safety and Efficacy of AIN457 in Noninfectious Uveitis Completed NCT00685399 Phase 2
39 Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis Recruiting NCT02595359 Phase 2
40 Ustekinumab (STELARA ) for the Treatment of Active Sight-Threatening Uveitis Recruiting NCT02911116 Phase 2
41 Safety and Effectiveness of the RHCIII-MPC Biosynthetic Cornea in Patients Requiring Anterior Lamellar Keratoplasty Not yet recruiting NCT02424006 Phase 1, Phase 2
42 Tocilizumab in the Management of Juvenile Idiopathic Arthritis Associated Uveitis Terminated NCT01603355 Phase 1, Phase 2
43 Treatment of Non-infectious Intermediate and Posterior Uveitis Associated Macular Edema With Intravitreal Methotrexate Terminated NCT01314417 Phase 1, Phase 2
44 Sub-Tenon's Injection of Triamcinolone and Ciprofloxacin in a Controlled-Release System for Cataract Surgery Terminated NCT00431028 Phase 1, Phase 2
45 Ustekinumab for Active Sight-Threatening Uveitis Withdrawn NCT01647152 Phase 1, Phase 2
46 Lucentis for New Onset Neovascular Glaucoma Withdrawn NCT00727038 Phase 1, Phase 2
47 Topical Cyclosporine vs. Placebo for Epiphora Associated With Docetaxel Withdrawn NCT00824811 Phase 2
48 Efalizumab to Treat Uveitis Completed NCT00280826 Phase 1
49 Cyclosporin Implant to Treat Uveitis Completed NCT00001737 Phase 1
50 Daclizumab and Sirolimus to Treat Uveitis Completed NCT00078689 Phase 1

Search NIH Clinical Center for Endophthalmitis

Cochrane evidence based reviews: endophthalmitis

Genetic Tests for Endophthalmitis

Anatomical Context for Endophthalmitis

MalaCards organs/tissues related to Endophthalmitis:

39
Eye, Liver, Endothelial, Lung, Testes, Prostate, Retina

Publications for Endophthalmitis

Articles related to Endophthalmitis:

(show top 50) (show all 810)
id Title Authors Year
1
Re: Javitt JC: Intracameral antibiotics reduce the risk of endophthalmitis after cataract surgery: does the preponderance of the evidence mandate a global change in practice? (Ophthalmology 2016;123:226-231). ( 27993282 )
2017
2
MALDI-TOF mass spectrometry for rapid diagnosis of postoperative endophthalmitis. ( 27989942 )
2017
3
Re: Javitt JC: Intracameral antibiotics reduce the risk of endophthalmitis after cataract surgery: does the preponderance of the evidence mandate a global change in practice? (Ophthalmology 2016;123:226-231). ( 27993280 )
2017
4
Liver Abscess and Metastatic Endophthalmitis Secondary to Klebsiella pneumoniae K1. ( 28050045 )
2017
5
Re: Jabbarvand etA al.: Endophthalmitis occurring after cataract surgery: outcomes of more than 480 000 cataract surgeries, epidemiologic features, and risk factors (Ophthalmology 2016;123:295-301). ( 27993276 )
2017
6
Endophthalmitis Prophylaxis Using a Single Drop of Thermoresponsive Controlled-Release Microspheres Loaded with Moxifloxacin in a Rabbit Model. ( 27933222 )
2016
7
CONCURRENT ENDOPHTHALMITIS AND ANTERIOR SEGMENT ISCHEMIA AFTER STRABISMUS SURGERY. ( 27124792 )
2016
8
Pediatric Infectious Endophthalmitis: A 271-case Retrospective Study at a Single Center in China. ( 27958225 )
2016
9
Intracameral cefuroxime in the prevention of postoperative endophthalmitis: an experience from Hong Kong. ( 27553051 )
2016
10
Possible Relation between Lack of Posterior Vitreous Detachment and Severe Endogenous Endophthalmitis. ( 27766175 )
2016
11
Brown Heroin-Associated Candida albicans Ventriculitis and Endophthalmitis Treated with Voriconazole. ( 27504092 )
2016
12
Stratifying the risk factors for endophthalmitis after cataract surgery. ( 27063544 )
2016
13
Postoperative Nocardia Endophthalmitis and the Challenge of Managing with Intravitreal Amikacin. ( 27034869 )
2016
14
Endogenous Fusarium Endophthalmitis in Diabetes Mellitus. ( 27990307 )
2016
15
Endophthalmitis prophylaxis in cataract surgery: Overview of current practice patterns around the world. ( 27981903 )
2016
16
Phacoantigenic Reaction Masquerading as Postoperative Endophthalmitis in a Silicone Oil-filled Eye. ( 27994397 )
2016
17
Ocular Infection: Endophthalmitis. ( 26501897 )
2016
18
The first case of fungal endophthalmitis caused by EmericellaA nidulans after cataract surgery. ( 27091580 )
2016
19
Microencapsulation of rifampicin for the prevention of endophthalmitis: In vitro release studies and antibacterial assessment. ( 26997423 )
2016
20
The Latest Updates and Management of Endophthalmitis. ( 27183288 )
2016
21
Histopathological clues in the diagnosis of fungal infection by Scedosporium in a case of endophthalmitis starting as conjunctivitis. ( 26968327 )
2016
22
Staphylococcus aureus Induced Endogenous Endophthalmitis with Pink Hypopyon. ( 27937098 )
2016
23
Chronic post-operative iris prosthesis endophthalmitis in a patient with traumatic aniridia: a case report. ( 27829389 )
2016
24
Pathogens and antibiotic sensitivities in endophthalmitis. ( 28013528 )
2016
25
Persistently Vitreous Culture-Positive Exogenous Fungal Endophthalmitis. ( 27644590 )
2016
26
Fulminant Endophthalmitis in a Child Caused by Neisseria meningitidis Serogroup C Detected by Specific DNA. ( 27000867 )
2016
27
First Report of Acute Postoperative Endophthalmitis Caused by Rothia Mucilaginosa after Phacoemulsification. ( 27103973 )
2016
28
Endophthalmitis after cataract surgery: epidemiology, risk factors, and evidence on protection. ( 27661662 )
2016
29
Case of late-onset bleb associated endophthalmitis caused by Rothia mucilaginosa. ( 27008920 )
2016
30
ACANTHAMOEBA ENDOPHTHALMITIS AFTER RECURRENT KERATITIS AND NODULAR SCLERITIS. ( 27152698 )
2016
31
Endophthalmitis or toxic anterior segment syndrome? ( 27515565 )
2016
32
Chronic mucocutaneous candidiasis presenting as Candida endophthalmitis. ( 27085277 )
2016
33
Postoperative endophthalmitis incidence after intravitreal therapy: a comparison of two different preoperative antibiotic prophylaxis. ( 27586671 )
2016
34
Aspergillus fumigatus Endophthalmitis with Necrotizing Scleritis following Pars Plana Vitrectomy. ( 27379189 )
2016
35
Correction for Pradeep et al., Draft Genome Sequence of Elizabethkingia anopheles, Isolated from a Postoperative Endophthalmitis Patient. ( 27932658 )
2016
36
An Intractable Case of Prototheca Keratitis and Chronic Endophthalmitis in Stevens-Johnson Syndrome With Boston Type 1 Keratoprosthesis. ( 27442317 )
2016
37
Clinical presentations, risk factors and outcomes of ceftazidime-resistant Gram-negative endophthalmitis. ( 27616274 )
2016
38
Microsporidial stromal keratitis and endophthalmitis in an immunocompetent patient. ( 27528053 )
2016
39
A severe Morganella morganii endophthalmitis; followed by bacteremia. ( 27092227 )
2016
40
Endophthalmitis caused by Non-tuberculous Mycobacterium: Clinical features, Antimicrobial Susceptibilities and Treatment Outcomes. ( 27048999 )
2016
41
25-GAUGE TROCAR CANNULA FOR ACUTE ENDOPHTHALMITIS-RELATED IN-OFFICE VITREOUS TAP AND INJECTION: Patient Comfort and Physician Ease of Use. ( 27471824 )
2016
42
Presumed Sterile Endophthalmitis After Intravitreal Triamcinolone (Kenalog)-More Common and Less Benign Than We Thought? ( 27071034 )
2016
43
Rising trends of endogenous Klebsiella pneumoniae endophthalmitis in Australia. ( 27564396 )
2016
44
Pediatric posttraumatic endophthalmitis. ( 27067874 )
2016
45
Comparison of Recent Studies of Postoperative Endophthalmitis From the Same National Database-Reply. ( 28033434 )
2016
46
Out of Sight: Culture-Negative Endocarditis and Endophthalmitis. ( 27637598 )
2016
47
Mitochondria mediates caspase-dependent and independent retinal cell death in Staphylococcus aureus endophthalmitis. ( 27551524 )
2016
48
OCHROCONIS GALLOPAVA ENDOPHTHALMITIS SUCCESSFULLY TREATED WITH INTRAVITREAL VORICONAZOLE AND AMPHOTERICIN B. ( 28002285 )
2016
49
Posttraumatic Endophthalmitis in children: Epidemiology, Diagnosis, Management, and Prognosis. ( 27929716 )
2016
50
Comparison of Recent Studies of Postoperative Endophthalmitis From the Same National Database. ( 28033440 )
2016

Variations for Endophthalmitis

Expression for Endophthalmitis

Search GEO for disease gene expression data for Endophthalmitis.

Pathways for Endophthalmitis

GO Terms for Endophthalmitis

Biological processes related to Endophthalmitis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules GO:0007157 9.4 ICAM1 SELE
2 activation of protein kinase activity GO:0032147 9.37 HMGB1 VEGFA
3 ovarian follicle development GO:0001541 9.32 ICAM1 VEGFA
4 positive chemotaxis GO:0050918 9.26 HMGB1 VEGFA
5 leukocyte cell-cell adhesion GO:0007159 9.16 ICAM1 SELE
6 positive regulation of receptor internalization GO:0002092 8.96 SELE VEGFA
7 endothelial cell chemotaxis GO:0035767 8.62 HMGB1 VEGFA

Molecular functions related to Endophthalmitis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 chemoattractant activity GO:0042056 8.96 HMGB1 VEGFA
2 structural constituent of eye lens GO:0005212 8.62 CRYAA CRYGS

Sources for Endophthalmitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....